Poly(oligo-D-arginine) with internal disulfide linkages as a cytoplasm-sensitive carrier for siRNA delivery

Molecular Therapy

Volumn 19, Issue 2, 2011, Pages 372-380

  Won, Young Wook ^a   Yoon, Sun Mi ^a   Lee, Kyung Mi ^b   Kim, Yong Hee ^a  

^a Hanyang University   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GLUTATHIONE; POLY(OLIGO DEXTRO ARGININE); SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL MIGRATION; CONFOCAL LASER MICROSCOPY; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; DISULFIDE BOND; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG RELEASE; DRUG STABILITY; GENE SILENCING; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; LIGHT SCATTERING; MOLECULAR WEIGHT; MOUSE; NONHUMAN; POLYMERIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; STEADY STATE; SUBCUTANEOUS TISSUE TUMOR; ZETA POTENTIAL;

ANIMALIA;

EID: 79551617516     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2010.242     Document Type: Article

References (23)

1. Kumar, P, Ban, HS, Kim, SS, Wu, H, Pearson, T, Greiner, DL et al. (2008). T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 134: 577-586.
2. Takei, Y, Kadomatsu, K, Yuzawa, Y, Matsuo, S and Muramatsu, T (2004). A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res 64: 3365-3370.
3. Whitehead, KA, Langer, R and Anderson, DG (2009). Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 8: 129-138.
4. Akhtar, S and Benter, IF (2007). Nonviral delivery of synthetic siRNAs in vivo. J Clin Invest 117: 3623-3632.
5. Zhang, M, Ishii, A, Nishiyama, N, Matsumoto, S, Ishii, T, Yamasaki, Y et al. (2009) PEGylated calcium phosphate nanocomposites as smart environment-sensitive carriers for siRNA delivery. Adv Mater 21: 3520-3525 .
6. Kim, SH, Jeong, JH, Kim, T-i, Kim, SW and Bull, DA (2008). VEGF siRNA delivery system using arginine-grafted bioreducible poly(disulfide amine). Mol Pharmaceut 6: 718-726.
7. Hoon Jeong, J, Christensen, LV, Yockman, JW, Zhong, Z, Engbersen, JF, Jong Kim, W et al. (2007). Reducible poly(amido ethylenimine) directed to enhance RNA interference. Biomaterials 28: 1912-1917.
8. Kim, PH, Kim, TI, Yockman, JW, Kim, SW and Yun, CO (2010). The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy. Biomaterials 31: 1865-1874.
9. Kim, TI, Lee, M and Kim, SW (2010). A guanidinylated bioreducible polymer with high nuclear localization ability for gene delivery systems. Biomaterials 31: 1798-1804.
10. Meng, F, Hennink, WE and Zhong, Z (2009). Reduction-sensitive polymers and bioconjugates for biomedical applications. Biomaterials 30: 2180-2198.
11. Kim, WJ, Christensen, LV, Jo, S, Yockman, JW, Jeong, JH, Kim, YH et al. (2006). Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. Mol Ther 14: 343-350.
12. Won, YW, Kim, HA, Lee, M and Kim, YH (2010). Reducible poly(oligo-d-arginine) for enhanced gene expression in mouse lung by intratracheal injection. Mol Ther 18: 734-742.
13. Chen, Q, Butler, D, Querbes, W, Pandey, RK, Ge, P, Maier, MA et al. (2010) Lipophilic siRNAS mediate efficient gene silencing in oligodendrocytes with direct CNS delivery. J Control Release 144: 227-232.
14. Lee, M, Rentz, J, Han, SO, Bull, DA and Kim, SW (2003). Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium. Gene Ther 10: 585-593. (Pubitemid 36432610)
15. Peng, Q, Zhong, Z and Zhuo, R (2008). Disulfide cross-linked polyethylenimines (PEI) prepared via thiolation of low molecular weight PEI as highly efficient gene vectors. Bioconjug Chem 19: 499-506.
16. Wu, G, Fang, YZ, Yang, S, Lupton, JR and Turner, ND (2004). Glutathione metabolism and its implications for health. J Nutr 134: 489-492.
17. Saito, G, Swanson, JA and Lee, KD (2003). Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv Drug Deliv Rev 55: 199-215.
18. Manickam, DS, Li, J, Putt, DA, Zhou, QH, Wu, C, Lash, LH et al. (2010). Effect of innate glutathione levels on activity of redox-responsive gene delivery vectors. J Control Release 141: 77-84.
19. Gosselin, MA, Guo, W and Lee, RJ (2001). Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjug Chem 12: 989-994.
20. Murata, N, Takashima, Y, Toyoshima, K, Yamamoto, M and Okada, H (2008). Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice. J Control Release 126: 246-254.
21. Guan, H, Zhou, Z, Wang, H, Jia, SF, Liu, W and Kleinerman, ES (2005). A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model. Clin Cancer Res 11: 2662-2669.
22. Kim, SS, Ye, C, Kumar, P, Chiu, I, Subramanya, S, Wu, H et al. (2010). Targeted delivery of siRNA to macrophages for anti-inflammatory treatment. Mol Ther 18: 993-1001.
23. Elouahabi, A and Ruysschaert, JM (2005). Formation and intracellular trafficking of lipoplexes and polyplexes. Mol Ther 11: 336-347.